Cargando…
Patient Enrichment for Precision‐Based Cancer Clinical Trials: Using Prospective Cohort Surveillance as an Approach to Improve Clinical Trials
Technological advances have led to the identification of biomarkers and development of novel target‐based therapies. While some novel therapies have improved patient outcomes, the prevalence and diversity of biomarkers and targets in patient populations, especially patients with cancer, has created...
Autores principales: | Dalton, William S., Sullivan, Daniel, Ecsedy, Jeffrey, Caligiuri, Michael A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032821/ https://www.ncbi.nlm.nih.gov/pubmed/29570791 http://dx.doi.org/10.1002/cpt.1051 |
Ejemplares similares
-
Precision Cancer Diagnostics: Tracking Genomic Evolution in Clinical Trials
por: Beca, Francisco, et al.
Publicado: (2016) -
Adaptive Trial Design: Could We Use This Approach to Improve Clinical Trials in the Field of Global Health?
por: Lang, Trudie
Publicado: (2011) -
Data Sharing, Clinical Trials, and Biomarkers in Precision Oncology: Challenges, Opportunities, and Programs at the Department of Veterans Affairs
por: Fiore, LD, et al.
Publicado: (2017) -
Evidence-based medicine and precision medicine: Complementary approaches to clinical decision-making
por: Chow, Ngai, et al.
Publicado: (2018) -
Digitizing clinical trials
por: Inan, O. T., et al.
Publicado: (2020)